✦ LIBER ✦

Pharmacokinetics of hydralazine and its acid-labile hydrazone metabolites in relation to acetylator phenotype

✍ Scribed by Danny D. Shen; James P. Hosler; Richard L. Schroder; Daniel L. Azarnoff

Book ID: 112472402
Publisher: Springer
Year: 1980
Tongue: English
Weight: 942 KB
Volume: 8
Category: Article
ISSN: 1573-8744
DOI: 10.1007/bf01059448

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of diltiazem and its me

Pharmacokinetics of diltiazem and its metabolites in relation to CYP2D6 genotype*

✍ Molden, Espen; Johansen, Per Wiik; Bøe, Grethe Helen; Bergan, Stein; Christensen 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

Comparative pharmacokinetics of acetyl s

Comparative pharmacokinetics of acetyl salicylic acid and its metabolites in children suffering from autoimmune diseases

✍ Hugo Juárez Olguín; Janett Flores Pérez; Ismael Lares Asseff; Arturo Loredo Abda 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

## Abstract The aim of the present study was to compare the effect produced by juvenile rheumatoid arthritis (JRA) or rheumatic fever (RF) on the pharmacokinetics of acetyl salicylic acid (ASA) and its metabolites in children with autoimmune diseases (AD). __Methods__—A prospective, open labelled s

Pharmacokinetics of tramadol enantiomers

Pharmacokinetics of tramadol enantiomers and their respective phase I metabolites in relation to CYP2D6 phenotype

✍ Emilio García-Quetglas; José Ramón Azanza; Belén Sádaba; María José Muñoz; Isabe 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 295 KB

Brain Regional Pharmacokinetics of p-Ami

Brain Regional Pharmacokinetics of p-Aminosalicylic Acid and Its N-Acetylated Metabolite: Effectiveness in Chelating Brain Manganese

✍ Hong, L.; Jiang, W.; Pan, H.; Jiang, Y.; Zeng, S.; Zheng, W. 📂 Article 📅 2011 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 714 KB

The occurrence of diarrhea not related t

The occurrence of diarrhea not related to the pharmacokinetics of MPA and its metabolites in liver transplant patients

✍ Zhang Wei Xia; Chen Yong Jun; Chen Hao; Chen Bing; Shi Min Min; Xie Jun Jie 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 242 KB

Pharmacokinetic differences between the

Pharmacokinetic differences between the enantiomers of lansoprazole and its metabolite, 5-hydroxylansoprazole, in relation to CYP2C19 genotypes

✍ M. Miura; H. Tada; N. Yasui-Furukori; T. Uno; K. Sugawara; T. Tateishi; T. Suzuk 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 237 KB